Cronos Group has finalized its acquisition of CanAdelaar, the leading cannabis company in the Netherlands' adult-use cannabis pilot program, for a base price of €57.5 million plus earnouts based on 2026 and 2027 EBITDA. This deal establishes Cronos as the market leader in Europe's largest adult-use cannabis market and supports its strategy to introduce innovative cannabis products in the Netherlands. CanAdelaar operates a large greenhouse facility and supplies nearly all licensed coffee shops in the pilot program, positioning Cronos for growth if the program expands beyond the initial ten municipalities. The acquisition also aligns with a regulated framework promoting responsible adult cannabis use and product quality.
Cronos Group shares are stable at USD 3.16 on Pluang as of Oct 15, 2026, 18:13 WIB, showing no change in the past day. The stock's market capitalization stands at $1.17 billion, reflecting its significant presence in the health sector. Trading volume recently reached 954,783 shares, indicating active investor interest around the time of this acquisition news.
